文献速递儿童呼吸儿童感染

鲁索替尼与托珠单抗治疗儿童中毒性表皮坏死松解后闭塞性细支气管炎

Ruxolitinib and Tocilizumab for Child Bronchiolitis Obliterans After Toxic Epidermal Necrolysis.
PubMed 文献 · Pediatrics · 2026-03-12

本文报告一例11岁中毒性表皮坏死松解症(TEN)患者出现严重支气管阻塞,经托珠单抗和鲁索替尼联合治疗后呼吸明显改善、支气管肺泡灌洗液促炎细胞因子下降,8个月随访未见不良反应。

要点

  • TEN可并发罕见但致命的呼吸道并发症,需警惕支气管阻塞。
  • 甲泼尼龙冲击治疗后仍进展的支气管阻塞,可考虑托珠单抗联合鲁索替尼。
  • 联合治疗后呼吸改善且8个月随访未观察到不良反应。

核心结论

  • 托珠单抗联合鲁索替尼可使TEN后严重支气管阻塞的11岁患者呼吸明显改善。

研究设计与样本

  • 个案报道,描述一例11岁TEN患者接受托珠单抗和鲁索替尼治疗的过程与随访。

主要发现

  • 甲泼尼龙冲击治疗后重复支气管镜显示近端支气管腔被粘连和黏膜膜进行性阻塞。
  • 多学科讨论后加用托珠单抗和鲁索替尼,呼吸明显改善且支气管肺泡灌洗液促炎细胞因子下降。
  • 8个月随访期间未观察到不良反应。

临床怎么用

  • 对TEN后出现进行性支气管阻塞且对甲泼尼龙冲击治疗反应不佳的患儿,可考虑托珠单抗联合鲁索替尼治疗。

局限性

  • 仅为单例个案报道,证据级别有限,结论需更大样本研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Toxic epidermal necrolysis (TEN) is a life-threatening mucocutaneous disorder with rare but potentially fatal respiratory complications. We present an exceptional documented case of TEN with severe bronchial obstruction successfully treated with tocilizumab and ruxolitinib in an 11-year-old patient. Despite early methylprednisolone pulse therapy, a repeat bronchoscopy showed progressive obstruction of proximal bronchial lumen by synechiae and mucosal membranes. Following multidisciplinary discussion, treatment was intensified with tocilizumab and ruxolitinib, resulting in marked respiratory improvement and decreased proinflammatory cytokines in bronchoalveolar lavage. No adverse effects were observed during 8 months of follow-up. Recent research supports Janus kinase inhibitors as targeted therapy in TEN.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Jaume L, Schmartz S, Welfringer-Morin A, et al. Ruxolitinib and Tocilizumab for Child Bronchiolitis Obliterans After Toxic Epidermal Necrolysis. Pediatrics. 2026. PMID: 41812997. doi:10.1542/peds.2025-073162

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。